Search Back New search Go to resultsDiseaseMain groupCross-Sectional, Transplantation, Cellular TherapySolid TumorsProtocol groupGastroenterologic OncologyGynecological OncologyVisceral SurgeryDiseaseColon CancerGastric CancerPeritoneal Carcinomatosis, SecondarySubgroupICD10C16.-C16.0C18.0C18.2C18.3C18.4C18.5C18.6C18.7C18.8C19C78.6MeSHColorectal NeoplasmsPeritoneal NeoplasmsSequenceChemotherapyChemo-substanceFluorouracilChemo-substanceFluorouracilChemo-substanceFluorouracilChemo-substanceFluorouracilNo. Substances1 RadiotherapySupportive therapySupportive substanceFilgrastimGranisetronNaCl 0.9%Supportive substanceFilgrastimGranisetronNaCl 0.9%Supportive substanceFilgrastimGranisetronNaCl 0.9%Supportive substanceFilgrastimGranisetronNaCl 0.9%No. Substances3Protocol classificationTherapy classificationcurrent standardIntensityStandard doseTherapy indicationTherapy phaseTherapy intentionpalliativeRisksEmetogenicity (MASCC/ESMO) only studiesPublicationAuthorGhanipour LDiseasePeritonealkarzinose, sekundärOriginUppsala University, Uppsala, SwedenProtocols in Revision 1 protocol foundProtocols under revision.EPIC - Fluorouracil 400, Peritoneal Carcinomatosis, Secondary (PID2709 V1.0)
